EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›TKNO

TKNO

Alpha Teknova, Inc.

Next earnings Aug 3, 2026 · consensus $-0.09 EPS, $11.2M rev

Last earnings -2.7% on 2026-05-06

Sell
$5.75
▲ +5.31%
$5.75▲ +8.90%
over 1Y
L $1.99EODHDH $6.37
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+5.3%
1W+11.4%
1M+43.8%
3M+112.2%
YTD+47.4%
1Y+8.9%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Sell
Quality
C-
Valuation
Fair value
Filings
Watch
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 12 analysts
Buy

Revenue grew 7.4% YoY; but unprofitable (net margin -42.6%).

Revenue (FY2025) $40.5M · FY2025

Alpha Teknova, Inc. shows $40.5M in FY2025 revenue (+7.4% YoY), a -42.6% net margin, and -25.1% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$36.9M$41.4M$36.7M$37.7M$40.5M
Gross profit$17.6M$17.5M$10.3M$7.23M$13.4M
Operating income-$12.0M-$49.7M-$35.6M-$26.1M-$17.0M
Net income-$9.80M-$47.5M-$36.8M-$26.7M-$17.3M
Diluted EPS-$0.61-$1.69-$1.16-$0.57-$0.32
Net margin-26.6%-114.6%-100.3%-70.9%-42.6%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$315M
EV / EBITDA—
EV / Sales7.8
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-5.6%
FCF yield-3.2%

Quality & risk

ROIC (est.)-16.4%
Free cash flow-$9.79M
Total debt$13.1M
Net cash-$7.21M
Altman Z-Score3.64 safe
Piotroski F-Score5/9

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.3%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Officer / director change2026-06-01
  2. 10-Q Quarterly report2026-05-07
  3. 8-K Earnings results2026-05-06
  4. DEF 14A Proxy statement2026-04-21
  5. 10-K Annual report2026-03-02
  6. 8-K Earnings results2026-02-26
  7. 10-Q Quarterly report2025-11-07
  8. 8-K Earnings results2025-11-06
  9. 10-Q Quarterly report2025-08-08

Recent filings

all on EDGAR ↗
4Period ending 2026-06-012026-06-02open ↗4Period ending 2026-06-012026-06-02open ↗4Period ending 2026-06-012026-06-02open ↗8-KPeriod ending 2026-05-272026-06-01open ↗10-QPeriod ending 2026-03-312026-05-07open ↗8-KPeriod ending 2026-05-042026-05-06open ↗ARSPeriod ending 2025-12-312026-04-21open ↗DEFA14AFiling2026-04-21open ↗DEF 14APeriod ending 2026-04-212026-04-21open ↗4Period ending 2026-02-152026-03-09open ↗4Period ending 2026-02-152026-03-09open ↗4Period ending 2026-02-152026-03-09open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueC
GrowthA-
ProfitabilityF
Financial healthB-
Momentum—
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$40.5M
+7.4% YoY
Net margin
-42.6%
ROE
-25.1%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$40.5M+7.4%
Net income-$17.3M+35.5%
Gross profit$13.4M+85.9%
Operating income-$17.0M+35.1%
Diluted EPS-$0.32+43.9%
Cash & equivalents$5.91M+59.4%
Total assets$104M-12.8%
Total liabilities$34.8M-4.3%
Stockholders' equity$68.8M-16.5%
Gross: 33.2%Op.: -41.9%L/E: 0.51x

Frequently asked

Is Alpha Teknova, Inc. (TKNO) a buy?
TKNO currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 7.4% YoY; but unprofitable (net margin -42.6%).
What is Alpha Teknova, Inc.'s quality score?
TKNO scores 53.86274509803922/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001850902, latest 10-Q filed 2026-05-07) · EODHD · as of 6/26/2026, 7:56:20 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-03-06
Lowell Matthew
Chief Financial Officer
Buy40.0K @ $2.19$87.6K
2026-03-06
Gunstream Stephen
President and CEO
Buy26.0K @ $2.15$55.8K
2025-06-27
DEMSKI MARTHA J
Director
Sell8.00K @ $5.06$40.5K
2025-06-17
Vos Alexander
Director
Award54.3K

Earnings history

beat/miss · move
2026-05-06Beat +14.7% est▼ -2.67%8-K ↗
2026-02-26Beat +4.1% est▲ +0.88%8-K ↗
2025-11-06Beat +16.6% est▼ -2.83%8-K ↗
2025-08-07Beat +31.4% est▼ -0.23%8-K ↗
2025-05-08—▲ +6.34%8-K ↗
2025-03-04—▲ +3.07%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Top Biotech Gainers: CRVO On Watch, SLP Scooped Up, LNAI Back In Compliance, NTHI Advances NEO212Bullish
nasdaq.com· 2026-06-17
Top Biotech Gainers: REPL On Track, SNSE Awaits Phase 2 Data, Keep An Eye On CCCC, IMRX SoarsBullish
nasdaq.com· 2026-06-01
Alpha Teknova, Inc. Q1 2026 Earnings Call SummaryBullish
finance.yahoo.com· 2026-05-07
Alpha Teknova (TKNO) Q1 2026 Earnings TranscriptBullish
finance.yahoo.com· 2026-05-06
Top Penny Stocks To Watch In April 2026Bullish
finance.yahoo.com· 2026-04-23
Sidoti Events, LLC's March Small-Cap Virtual ConferenceBullish
finance.yahoo.com· 2026-03-18

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score54 vs 67
Revenue growth7.4% vs 7.1%
Net margin-42.6% vs 10.5%
Return on equity-25.1% vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 4d
Bullish
+0.10
vs typical · 4 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.